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Bitter taste of ofloxacin, a broad spectrum bactericidal agent, is masked and orally disintegrating 
tablets were formulated. The bitter taste is masked by forming complex between drug and weak cation 
exchange resins, Tulsion 335 and Indion 204. Effect of pH and drug:resin ratio on the drug loading 
was studied. Maximum drug loading was observed at pH 6. Ratio of 1:2 of drug:resin masked almost 
complete bitterness of ofloxacin. Formation of complexes was confirmed by IR spectroscopy. Physical 
characterization of taste masked complexes was carried out. Present work envisages the taste masking 
of ofloxacin and development of orally disintegrating tablets. The effect of pH and resin quantities on 
drug loading were studied to find the optimum conditions of drug loading for complete taste masking. 
Effect of superdisintegrants like sodium starch glycolate, croscarmellose sodium and polyplasdone 
XL at varying level on physical parameters of compressed tablets was also assessed. The formulations 
containing 5 % w/w polyplasdone XL showed about 90 % of drug release within 5 minutes. No significant 
differences were observed in the physical parameters of resinates as well as tablets prepared from Tulsion 
335 and Indion 204. 
Uniterms: Dispersion time. Indion 204. Ion exchange resin. Ofloxacin. Orally disintegrating tablets. 
Tableting properties. Tulsion 335. Wetting time.
O gosto amargo de ofloxacina, agente bactericida de largo espectro, é mascarado e formularam-se 
comprimidos dispersíveis. O sabor amargo é mascarado pela formação de complexo entre o fármaco e 
resinas de troca catiônica fraca, Tulsion 335 e Indion 204. Efeito do pH e da proporção fármaco: resina 
sobre a carga de fármaco foi estudada. Carga de fármaco máxima foi observada em pH 6. Proporção 1:2 do 
fármaco: resina mascarou quase completamente o gosto amargo de ofloxacina. A formação de complexos 
foi confirmada por espectroscopia no IV. Caracterização física dos complexos de sabor mascarado foi 
realizada. O presente trabalho preconiza o mascaramento do gosto de ofloxacina e desenvolvimento 
decomprimidos por via oral, se desintegrando. O efeito do pH e da resina quantidades de carga de 
fármaco foram estudadas paraencontrar as condições óptimas de carga de fármaco para dissimulação 
do saborcompleto. Efeito da superdisintegrants como amido glicolato de sódio, croscarmelose sódica 
e Polyplasdone XL em diferentes níveis de parâmetros físicos de comprimidos também avaliados foi 
avaliada. As formulações contendo 5 %w/w Polyplasdone XL mostraram cerca de 90% de libertação do 
fármaco no prazo de 5 minutos. Não foram observadas diferenças significativas nos parâmetros físicos 
de resinatosbem como comprimidos preparados a partir de Tulsion 335 e Indion 204.
Unitermos: Tempo de dispersão. Indion 204. Resina de troca iônica. Ofloxacina. Comprimidos de 
desintegração oral. Comprimidos/desenvolvimento/propriedades. Tulsion 335.
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INTRODUCTION
Unpleasant taste mainly bitterness had lead to dilem-
ma for modern pharmaceutical science. This undesirable 
taste diminishes the acceptance and usefulness of many 
beneficial, safe and efficacious drugs. Thus elimination 
or reduction of bitterness is an important mainstay of 
product evaluation in oral pharmaceutical formulation.
The proven methods for bitterness reduction and 
inhibition have resulted in improved palatability of the 
oral pharmaceuticals. Methods of taste masking employ 
pH sensitive polymers like Eudragit E 100 (aminoalkyl-
methacrylate copolymers) (Shishu, Kapoor, Kamalpreet, 
2009), polyacrylic acid ion exchange resin Indion 204, 
Indion 214, Indion 234, Indion CRP 244 and CRP 254, 
Tulsion 335, Amberlite IRP64 (Cation exchange resins) 
(Venkatesh, Jha, Karki, 2009; Mundada et al., 2008; Avari, 
Bhalekar, 2008; Pisal et al., 2004; Manek, Kamat, 1981; 
Tawakkul, 2009; Amin et al., 2005; Leonard, Cooper, 
1998; Metcalf, Purdy, 2001).
Extensive research has been carried out for the 
development of taste masked dispersible, oro-dispersible 
(Venkatesh, Jha, Karki, 2009), fast dissolving and mouth 
dissolving tablets (Amin et al., 2005) using ions exchange 
resins and pH sensitive polymers (Shishu, Kapoor, Kamal-
preet, 2009; Venkatesh, Jha, Karki, 2009). Strong cation 
exchange resin, Amberlite IRP69 was evaluated for taste 
masking, improvement of physicochemical properties of 
actives and subsequently formed resinate for sustaining 
the drug release (Khan et al., 2007; Junyaprasert, Man-
wiwattanakul, 2008). The microencapsulated resinates 
were evaluated for controlled release characteristics 
(Kadam, Sakarkar, Kawtikwar, 2008). Enteric coating by 
using different coating materials was also employed to 
mask the bitter taste of dihydroartemisinin (Shahzad et 
al., 2011). In addition to this, various superdisintegrants 
have been employed for the development of dispersible 
tablets (Damodharan, Manimaran, Suresh Kumar, 2009). 
Thus, taste masking of oral pharmaceuticals has be-
come potential tool to improve patient compliance and 
commercial success of product (Nanda, Kandarapu, 
Garg, 2008; Wagh, Ghadlinge, 2009; Hiremath, Shastry, 
Shrinath, 2004).
Ion-exchange resins are water-insoluble, cross-linked 
polymers containing salt-forming groups in repeating posi-
tions on the polymer chain. Drug is bound to the resin by 
repeating exposure of the resin. These complexes reduce 
the solubility of the drug in saliva but releases drug in 
stomach so that the bioavailability of the drug is not af-
fected (Banker, Anderson, 1991). Carboxylic resins were 
reported to have higher exchange capacities (about 10 meq/g) 
than sulfonic acid resins (about 4 meq/g) or amine resins (Amin 
et al., 2005). Therefore, Indion 204 and Tulsion 335 were 
selected as resins for complex preparation.
In the present work, ofloxacin is selected as a suit-
able candidate due to its major disadvantage of bitterness. 
The bitterness may be masked to some extent by using 
sweetening and flavoring agent but it is not satisfactory as 
an unpleasant aftertaste may still remain in mouth. Thus 
complete masking of bitterness and formulate it into pal-
atable dosage form especially for pediatric and geriatric 
patients become necessity. Liquid formulations have the 
problem of dose accuracy and stability. This problem is 
not seen in case of solid orals. But the major disadvantage 
associated with solid oral dosage forms is that the intact 
unit is difficult to swallow especially in pediatric and 
geriatric population. These problems can be overcome 
by formulating the drug into dispersible tablet. Thus in 
present research work, taste masked orally disintegrating 
ofloxacin tablets were developed. The weak cation ex-
change resins, Indion 204 and Tulsion 335 were evaluated 
at varying proportion to determine taste masking potential 
and minimum ratio of resin required for taste masking. 
Effects of different disintegrants at varying levels were 
studied to develop the formulation with minimum disin-
tegration time. The study also envisaged the effect of pH 
on drug loading so as to find out the optimum condition 
of drug binding.
MATERIAL AND METHOD
Material
Ofloxacin was received as research sample from El-
der pharmaceuticals Ltd., Navi Mumbai, India. Indion 204 
and Tulsion 335 were procured from Ion Exchange India 
Ltd., Mumbai and Thermax Ltd., Pune respectively. poly-
plasdone XL (Crospovidone), sucralose and starch 1500 
(Pregelatinized starch) were procured from International 
Specialty Product Ltd., Mumbai, India, Gangwal Chemi-
cals Pvt. Ltd., Mumbai, India and Colorcon Asia Pvt. 
Ltd., Goa, India respectively. Ac-Di-Sol (Croscarmellose 
sodium) and Avicel PH 101(Microcrystalline cellulose) 
were supplied by Signet Chemical Corporation Pvt. Ltd., 
Mumbai, India. Pearlitol SD 200 (mannitol) and Glycolys 
(sodium starch glycolate) were provided by Roquette India 
Pvt. Ltd., Mumbai, India. Peppermint flavor, Aerosil 200 
and magnesium stearate were obtained by Keva Flavours 
Pvt., Ltd, Mumbai, India, Evonik Degussa India Pvt. Ltd., 
Mumbai, India and Loba Chemie Pvt. Ltd., Mumbai, India 
respectively. All other chemicals were of analytical grade 
and were used as received.
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Methods
Preparation of drug-resin complexes
The selected drug is basic in nature, with amine func-
tional group, therefore cation exchange resins were selected 
(Indion 204 and Tulsion 335).
The drug-resin complexes were prepared by the 
batch process (Kadam, Sakarkar, Kawtikwar, 2008). 
Known weight of ion exchange resin was taken and 
slurred in 100 mL of distilled water. An accurately 
weighed amount of ofloxacin (1 g) was added to the 
slurry and stirred on magnetic stirrer (2MLB Magnetic 
Stirrer, Remi Equipments, Mumbai, India) for 5 hours. 
Resinates obtained were washed with copious amount 
of water to remove uncomplexed drug. The complexes 
were dried in a hot air oven (SMC-120, Spectrum Pvt. 
Ltd., Mumbai, India) at 60 °C for 4 hours and then stored 
in tightly closed desiccator.
Optimization of drug loading
·  Effect of pH on drug loading
A series of solutions were prepared which contained 
fixed quantity (1g) of resin (Tulsion 335 and Indion 204) 
in 100 mL distilled water and about 1 g of ofloxacin. The 
pH was adjusted at 1.2, 2.0, 3.0, 4.0, 5.0, 6.0, 7.0 and 8.0 
and stirred on magnetic stirrer for 5 hours. The resinates 
were collected by filtration, washed with copious amount 
of water to remove uncomplexed drug and dried at 60 °C 
and then stored in tightly closed desiccator.
·  Effect of drug resin ratio on loading
Three batches were prepared containing drug:resin 
in the ratio of 1:1, 1:2, 1:3 with Tulsion 335 and Indion 
204. The pH was maintained at 6 and stirred for 5 hours. 
Resinates obtained were separated by filtration, washed 
with water to remove uncomplexed drug and dried at 
60 °C.
·  Taste evaluation of complexes (Mundada et al., 
2008)
The taste of complexes was checked by panel 
method. For this purpose 10 human volunteers in the age 
group of 19 to 22 years were selected. The study pro-
tocol was explained and written consent was obtained 
from volunteers. About 100 mg of drug equivalent com-
plex was placed on tongue and taste evaluated after 10 
seconds. The taste given by each volunteer was recorded 
against pure drug using a numerical scale as a bitter-
ness level (3 = Very biter; 2 = Bitter; 1 = Slightly bitter; 
0 = Normal). Mean of all the scores given by volunteers 
for each formulation were taken into consideration for 
taste evaluation purpose. Minimum mean value of taste 
evaluation score indicates better taste masking.
· Determination of drug content of complexes (Ava-
ri, Bhalekar, 2004)
About 100 mg of complex was accurately weighed 
and taken in 100 mL volumetric flask. Volume was made 
with 0.1 N hydrochloric acid. Contents of the flask 
were sonicated for 20 minutes (3.5L 100, PCi, Mumbai, 
India). Solution was then filtered. From filtrate, further 
dilution was made with 0.1 N hydrochloric acid and the 
absorbance was measured at 294 nm using UV double 
beam spectrophotometer (Shimadzu 1700 (E) 23, Japan).
FTIR studies
Studies were carried out to confirm the formation 
of complexes of ofloxacin. The IR spectra of pure drug, 
Indion 204, Tulsion 335 complexes and their physical 
mixtures were observed for characteristics peaks (FTIR-
8001, Shimadzu, Japan).
Evaluation of physical properties of taste 
masked complexes
Prepared complexes were evaluated for different 
physical parameters like moisture content, shape, angle 
of repose, bulk density, tapped density, compressibility 
index, Hausner ratio (Avari, Bhalekar, 2004). The com-
plexes were observed under compound microscope 
(Metzer, India) at 10X magnification for shape deter-
mination. Moisture content of resinates was measured 
using halogen moisture analyzer (MB50C, Citizen 
Scale India Pvt. Ltd., Mumbai, India) at 105 0C. Angle 
of repose of was measured using fixed funnel method. A 
funnel with 10 mm inner diameter of stem was fixed at a 
height of 2.5 cm over the platform. About 10 g of sample 
was slowly passed along the wall of funnel till the tip of 
the pile formed touches the stem of the funnel. A circle 
was drawn around the pile base and the radius of powder 
cone was measured. Angle of repose was calculated from 
three averages using formula, q = tan-1( Height/Radius). 
Bulk and tapped density determinations were carried out 
as per method (Method II) described in United States 
Pharmacopoeia (USP) 24.
In vitro drug release studies from complexes
The complexes were subjected to in vitro dissolu-
tion testing using USP dissolution test apparatus type II 
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(TDT-08L, Electrolab Ltd., Mumbai, India). Weighed 
quantity of complexes equivalent to 100 mg of ofloxacin 
were suspended in 900 mL of 0.1 N HCl and quantity of 
drug released was determined periodically using spectro-
photometric method of analysis at 294 nm.
Formulation of dispersible tablets
Poor compressibility of resinates and excess friabil-
ity of the compressed tablets shifted direct compression 
approach to wet granulation. Tablet consist of resinates 
equivalent to 100 mg ofloxacin. Sodium starch glycolate, 
Polyplasdone XL and croscarmellose sodium as super-
disintegrants. Microcrystalline cellulose, pregelatinized 
starch and Pearlitol SD 200 were used as diluents. All 
the ingredients were sifted through No. 30 (600 µ) sieve 
and dry blended for 10 minutes in double cone blender at 
14 ± 2 rpm. The blend was wet granulated using deminer-
alised water as granulating fluid. Wet granules were dried 
in tray dryer (Neel Enterprises, Mumbai, India) at 60 °C for 
4 hours. The granules were sized through No. 20 (850 µ) 
sieve. Particle size distribution of the sized granules was 
carried out to get an idea of average particle size distri-
bution using mechanical sieve shaker (Jayant Scientific 
Industries, Mumbai, India. Superdisintegrants, in varying 
concentrations, along with Pearlitol SD 200, sucralose 
(sweetner), Peppermint flavor, Aerosil 200 and magnesium 
stearate were added extra granularly. The moisture content 
of the lubricated blend was determined using halogen 
moisture analyzer at 105 0C for 5 minutes. Compression 
was carried out using ten station rotary tablet compression 
machine (Pilot Press Tablet Machine, Chamunda Pharma 
Machinery Pvt. Ltd., Ahmedabad, India). The weight of 
tablets were adjusted to 600 ± 10 mg using 12.8 mm flat 
faced with break line punches and compressed at hardness 
of 5-7 kg/cm2.
Evaluation of dispersible tablets
Prior to compression, lubricated granules were char-
acterized for physical parameters like angle of repose, bulk 
and tapped densities, % compressibility and Hausner ratio 
(Reddy, Mutalik, Reddy, 2003; Kuksal, 2006) The proper-
ties of the compressed tablet, such as thickness (Digital 
Vernier Caliper, Mitutoya Corp.), hardness (Mht-20, 
Monsanto Tablet Hardness Tester, Campbell Electron-
ics, Mumbai, India), friability (EF-1W, Electrolab Ltd., 
Mumbai), weight variation, disintegration time (ED-2L, 
Electrolab Ltd., Mumbai.) and content uniformity were 
determined using reported procedure. The content was 
determined as described for complexes. Tablets were also 
evaluated for in vitro dispersion time (Mohire, Yadav, 
Gaikwad, 2009); wetting time, water absorption ratio and 
uniformity of dispersion test (Jacob, Shirwaikar, 2009).
In vitro dissolution studies
Tablets were subjected to in vitro dissolution testing 
as per procedure and conditions described for in vitro dis-
solution of taste masked complexes.
TABLE I - Composition of ofloxacin orally disintegrating tablets (600 mg) containing sucralose 1 %w/w, peppermint flavor 1%w/w, 
Aerosil 0.5%w/w and magnesium stearate 1%w/w
Ingredients (mg) F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 F11 F12
Intra granular
Tulsion 335 200 200 200 200 200 200 - - - - - -
Indion 204 - - - - - - 200 200 200 200 200 200
Sodium starch glycolate 6 9 - - - - 6 9 - - - -
Croscarmellose sodium - - 6 9 - - - - 6 9 - -
Polyplasdone XL - - - - 6 9 - - - - 6 9
Microcrystalline cellulose 171 159 171 159 171 159 171 159 171 159 171 159
Pregelatinized starch 18 18 18 18 18 18 18 18 18 18 18 18
DM water q.s. q.s. q.s. q.s. q.s. q.s. q.s. q.s. q.s. q.s. q.s. q.s.
Extra granular
Pearlitol SD 200 72 72 72 72 72 72 72 72 72 72 72 72
Sodium starch glycolate 12 21 - - - - 12 21 - - - -
Croscarmellose sodium - - 12 21 - - - - 12 21 - -
Polyplasdone XL - - - - 12 21 - - - - 12 21
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RESULTS AND DISCUSSION
The batch method was preferred for the preparation 
of resinates because of its convenience. Time to reach 
equilibrium was determined by stirring the drug and 
resin at various time intervals (1 to 7 hours) and it was 
found that 5 hours is optimum period. The loading of 
ofloxacin onto ion exchange resin is an equilibrium pro-
cess which depends upon the presence of cationic form of 
the drug in solution. The presence of cationic form was 
influenced by pH of the solution; therefore loading effi-
ciency depends on pH. To investigate this behavior the pH 
of drug-resin solution was varied keeping the drug resin 
in the ratio of 1:1. Ofloxacin-Ion exchange resin complex-
ation involves the exchange of ionizable drug and metal 
ions in resin, which in turn depends on the pKa of drug and 
resin. Such a mode of complexation between amino group 
of ofloxacin and –COO– K+ functionality of Tulsion and 
Indion can be affected by the pH of the reacting media. The 
complexation was enhanced with increasing pH from 1 to 
6. A maximum of 95.51 ± 1.42% w/w and 94.15 ± 2.08 % 
w/w drug loading was obtained for Tulsion 335 and Indion 
204 respectively at pH 6 (i.e., at pKa of ofloxacin). As 
shown in Figure 1, as pH increased above 6, the percent-
age drug loading decreased. The pH of the solution affects 
both solubility and the degree of ionization of drug and 
resin. The results can be attributed to the fact that ofloxacin 
hydrochloride has a pKa between 6.08 hence will have 
maximum solubility and complete ionization near to this 
pH value. The decreased complexation at lower pH is 
due to excess H+ ions in the solution, which have more 
binding affinity to the –COO– groups of resin and com-
pete with the drug for binding (Pisal et al., 2004). Since 
maximum loading of ofloxacin on both the resins, Tulsion 
335 and Indion 204 was seen at pH 6, it was selected for 
complexation of ofloxacin. Effect of drug:resin ratio on 
drug loading is shown in Figure 2. Results revealed that as 
the drug:resin ratio increased, the % drug loading was in-
FIGURE 1 - Effect of pH on drug loading. Mean ± SD (n = 3).
FIGURE 2 - Effect of drug:resin ratio on drug loading. Mean 
± SD (n = 3).
TABLE II - Evaluation of taste of complexes
Volunteer 1 2 3 4 5 6 7 8 9 10 Mean 
Pure Drug 3 3 3 3 3 3 3 3 3 3 3
Drug-Tulsion 335 complex 1 : 1 3 3 2 3 3 2 3 2 2 3 2.6
1 : 2 1 0 0 0 1 0 0 0 1 0 0.3*
1 : 3 0 0 1 0 0 0 0 1 0 0 0.2*
Drug-Indion 204 complex 1: 1 2 3 3 2 3 2 3 2 3 3 2.6
1 : 2  0 1 0 0 0 1 0 1 0 1 0.4*
1 : 3 0 0 0 0 0 0 1 1 0 0 0.2*
3 = Very bitter; 2 = Bitter; 1 = Slightly bitter; 0 = Normal
creased. Drug loading was increased from about 88% w/w 
to 95% w/w when drug:resin ratio was increased from 
1:1 to 1:2 for both the resins. Beyond 1:2 drug:resin ratio, 
ofloxacin loading was remained constant. Both the resins 
have shown similar behavior for drug loading.
Statistical analysis was done by using non paramet-
ric Kruskal-Wallis test followed by Dunn pos-hoc test for 
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the comparison between pure drug and test formulations. 
*P<0.001 was considered as significant.
Results of taste evaluation by panel method as 
shown in the Table II revealed that Tulsion 335 and Indion 
204 mask the bitter taste of drug completely at 1:3 and al-
most completely at 1:2 ratios. Thus, ratios (1:2) at which, 
complexes mask the bitter taste of drug completely with 
the aid of sweetener and flavor were considered for further 
studies. Results of physical properties of taste masked 
complexes are shown in Table III.
Particle size distribution shown uniform distribu-
tion of granules. NMT 78% of particle were found below 
No. 80 (850 µ) sieve. Angle of repose is an indication of 
interparticle frictional force of a sample that in turn may 
affect its flowability. It has been reported that material 
having angle of repose ≤30° have good flowability. The 
angle of repose was found to be less than 30° suggesting 
that granules have good flowability. This is a very criti-
cal parameter, as flow property may affect the die filling; 
tablet weight and drug content present in the tablet, and is 
important for compression of tablets.
Bulk density is an indication of packing proper-
ties of material. Variations in the bulk density can cause 
change in die fill volume. The bulk density of powder 
depends primarily on particle size distribution, particle 
shape and frequency of particles to adhere together. The 
TABLE III - Physical properties of taste masked complexes
Parameter Drug-Tulsion 335 Complex Drug-Indion 204 Complex
Shape Irregular Irregular 
Moisture content 7.48% w/w 9.32% w/w
Angle of Repose (q) 27.7° 28.06°
Bulk density (g/cm3) 0.57 ± 0.05 0.56 ± 0.03
Tap density (g/cm3) 0.68 ± 0.03 0.66 ± 0.04
Carr’s index (%) 16.18 15.15
Hausner Ratio 1.19 1.18
FIGURE 3 - FT-IR spectra of ofloxacin, Indion 204, Tulsion 335 and complex of ofloxacin with Indion 204 and Tulsion 335.
particles may pack in such a way so as to leave large gaps 
between their surfaces resulting in a light powder of low 
bulk density. On the other hand, the smaller particles may 
pack between the larger ones to form a heavy powder or 
one of high bulk density.
It has been reported that bulk density less than 
1.25 g/cm3 indicate good flowability (Wells, 1988). It is 
evident from table III that complexes have shown bulk 
density in the range 0.56-0.57 (g/cm3) which indicates 
good compression properties.
Carr’s compressibility index i.e. % compressibility 
and Hausner ratio indicates the packing ability of powders. 
When compressibility index values ranges from 5 to 16 
and Hausner ratio closer to 1.25, the materials have accept-
able flow property and packing ability. The results have 
shown that the complexes possessed good flow properties 
and packing ability.
IR spectrum of Tulsion 335 and ofloxacin com-
plex as well as Indion 204 and ofloxacin complex show 
absence of peak at 3397 cm-1 in drug-resin complex 
corresponds to complexation of amine group in the drug 
with resin. The absence of peaks 2685-3044 cm-1 due to 
dimerization of carboxylic acid groups in the drug-resin 
complex denotes that breaking of acid dimmers during 
complexation, which signifies that drug-resin complex 
formation. Amino group of drug was interacted with 
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FIGURE 4 - In vitro drug release profile of complexes. 
Mean ± SD (n = 3).
carboxylic group of Tulsion 335 and Indion 204. Drug 
content in the taste masked complexes was fund in the 
range of 98.4 to 99.2%.
In vitro dissolution studies of drug:resin complexes 
(1:2) in 0.1 mL 0.1 N HCl at 50 rpm using USP type II 
dissolution test apparatus shown more than 80% drug 
release within 5 minutes. Both the complexes have shown 
almost similar release profiles with F2 (similarity) factor 
value of 95.1 (Figure 4). The prepared powder blends 
of various formulations were evaluated for physical 
parameters which have shown excellent flow proper-
ties. The moisture content values of blends were in the 
range of 2.13 - 2.58% w/w for all formulations. Tablets 
of all the batches pass the test for friability and weight 
TABLE IV - Characterization of ofloxacin orally disintegrating tablets. All values indicate mean ± SD (n=10)
Formulation 
Code
Wetting time (sec)
Water absorption 
ratio
% Drug content
In vitro disintegration 
time (sec)
In vitro dispersion 
time (sec)
F1 282 ± 4 83 ± 4 97.9 ± 0.9 112 ± 6 94 ± 3
F2 257 ± 3 79 ± 2 98.5 ± 1.1 97 ± 3 83 ± 2
F3 148 ± 4 69 ± 1 96.4 ± 0.7 55 ± 5 48 ± 3
F4 94 ± 7 62 ± 2 99.0 ± 0.4 41 ± 2 33 ± 2
F5 52 ± 2 47 ± 4 98.7 ± 0.8 31 ± 3 24 ± 2
F6 33 ± 3 44 ± 2 99.6 ± 0.5 22 ± 3 19 ± 3
F7 342 ± 9 78 ± 3 97.1 ± 0.6 121 ± 5 98 ± 3
F8 314 ± 5 72 ± 1 98.7 ± 0.5 109 ± 6 92 ± 4
F9 153 ± 2 69 ± 2 99.2 ± 0.8 65 ± 7 53 ± 4
F10 95 ± 3 65 ± 3 99.5 ± 0.2 49 ± 8 39 ± 2
F11 48 ± 2 58 ± 3 97.5 ± 1.6 37 ± 4 29 ± 3
F12 29 ± 2 38 ± 1 100.2 ± 0.3 28 ± 5 21 ± 1
variation. Also the compressed tablets were evaluated 
for various physical parameters; results are depicted 
in Table IV.
Tablets of all the batches pass the test of uniformity 
of dispersion. The results revealed that the tablets of 
batches (F6) formulated with 5% w/w of Polyplasdone 
XL has shown remarkably less wetting time, disinte-
gration time and dispersion time. CDER (Center for 
Drug Evaluation and Research) recommend that orally 
disintegrating tablets be considered solid oral prepara-
tions that disintegrate rapidly in the oral cavity, with an 
in-vitro disintegration time of approximately 30 seconds 
or less, when based on the United States Pharmacopeia 
(USP) disintegration test method or alternative. Formu-
lation batches containing Polyplasdone XL (3% w/w 
and 5% w/w) have shown desired disintegration time. 
Figure 5 and 6 show in vitro ofloxacin release from the 
taste masked compressed tablets containing Tulsion 335 
and Indion 204 respectively. Tablets containing Sodium 
starch glycolate and croscarmellose sodium shown re-
markably decrease in drug release at each time point dur-
ing dissolution studies as compared to Polyplasdone XL 
at 3% w/w level. Whereas when Polyplasdone XL was 
used at 5% w/w concentration, tablets released nearly 
90% of drug within 5 minutes which can be correlated 
to the results obtained for wetting time, disintegration 
time and in vitro dispersion time. The F2 value for for-
mulation batches containing 5% w/w Polyplasdone XL 
(F6 and F12) was found to be 93.9 which conclude the 
comparable release profiles for both the resins. Also, 
in vitro drug release data of tablets matched with that 
obtained for complexes.
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CONCLUSION
Taste masked orally disintegrating ofloxacin tablets 
were formulated for more palatable and compliance disin-
tegration in oral cavity using Tulsion 335 and Indion 204 
effectively masked bitter taste of ofloxacin. The maximum 
drug loading was found at pH 6 which increased propor-
tionately with increase in amount of resin. The formula-
tions containing Polyplasdone XL as disintegrant shown 
tablets with desired physical parameters and about 90% 
of drug was released within 5 minutes when Polyplasdone 
XL used at 5% w/w level.
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